The advertisement promotes GOMEKLI (mirvetuximab) as a treatment option, highlighting its classification by the National Comprehensive Cancer Network and providing important safety information and warnings.
Creative Information
| CID: | d7c12ba6-4c61-421a-b9ec-3847de9e6cce |
| CRID: | 82_7427-923926 |
| Domain: | ajmc.com |
| Seat: | PP |
| Size: | 728x90 |
| Bid: | $0.40 |
| Timestamp: | 11/1/2025, 2:56:07 AM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/12/2025, 3:17:59 PM | 7.38s | |
| adomain_analysis | success | 11/12/2025, 4:50:39 PM | 5.11s | |
| adomain_capture | success | 11/12/2025, 4:50:15 PM | 0.12s | |
| ad_render | success | 11/12/2025, 3:17:52 PM | 23.12s | |
| brand_mapping | success | 11/12/2025, 2:58:22 PM | 0.12s | |
Analysis Results
Ad Format: banner
Brands: AJMC
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 325.01 KB | ||||||||||||||||||||||
| Render Time: | 7.75 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 325.01 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


